ResearcherFirst Hospital of Jilin UniversityNo recent work listed

Yanfang Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2478-1521; OpenAlex author ID A5025551264. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma. Last author DOI 10.1093/pcmedi/pbac010 ↗
Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma. Last author DOI 10.1016/j.cca.2021.03.020 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ang Li · 2 shared papers, 2021–2022 · strength 0.36
- Paper A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ducta… DOI 10.1093/pcmedi/pbac010 ↗
- Paper Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarc… DOI 10.1016/j.cca.2021.03.020 ↗
Bicheng Ye · 1 shared paper, 2022 · strength 0.19
- Paper A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ducta… DOI 10.1093/pcmedi/pbac010 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.